| Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial K Shitara, M Özgüroğlu, YJ Bang, M Di Bartolomeo, M Mandalà, MH Ryu, ... The Lancet 392 (10142), 123-133, 2018 | 1132 | 2018 |
| Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial SY Rha, DY Oh, P Yañez, Y Bai, MH Ryu, J Lee, F Rivera, GV Alves, ... The Lancet Oncology 24 (11), 1181-1195, 2023 | 42 | 2023 |
| Doxorubicin and BOOP. A possible near fatal association. C Jacobs, M Slade, B Lavery Clinical oncology (Royal College of Radiologists (Great Britain)) 14 (3 …, 2002 | 34 | 2002 |
| Scheduling multi-colour print jobs with sequence-dependent setup times AP Burger, CG Jacobs, JH van Vuuren, SE Visagie Journal of Scheduling 18, 131-145, 2015 | 28 | 2015 |
| A model to calculate the cost of logistics at a macro level: a case study of South Africa FJ Botes, CG Jacobs, WJ Pienaar Southern African Business Review 10 (3), 1-18, 2006 | 24 | 2006 |
| Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer T Kuehr, P Ruff, BL Rapoport, S Falk, F Daniel, C Jacobs, N Davidson, ... BMC cancer 4, 1-10, 2004 | 15 | 2004 |
| Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma IN Olver, MJ Byrne, E Walpole, D Vorobiof, C Jacobs, K Maart, S Hewitt, ... European Journal of Cancer 43 (12), 1829-1832, 2007 | 12 | 2007 |
| Phase II study of pegylated liposomal doxorubicin (Caelyx) in advanced hepatocellular carcinoma (HHC). P Ruff, SD Moodley, BL Rapoport, MR Chasen, C Jacobs, D Hacking, ... Annals of Oncology 11, 69-70, 2000 | 3 | 2000 |
| 630 Implementation and progress review of a nurse-led family history risk assessment clinic EM Grimsey, DC Howlett, SM Allan, EF Shah, L Apthorp, R Guy, ... EJC Supplements 3 (8), 241, 2010 | 2 | 2010 |
| Fourth annual state of logistics survey for South Africa 2007: logistics for regional growth and development HW Ittmann, DJ King, EL Maspero, FE Van Dyk, W Bean, E Willemse, ... | 2 | 2008 |
| Third annual state of logistics survey for South Africa 2006: Implementing logistics strategies in a developing economy HW Ittmann, C Schoeman, DJ King, AH Naude, EN Ralehoko, IA Meyer, ... CSIR, 2007 | 2 | 2007 |
| First state of logistics survey for South Africa 2004: The case for measurement and revitalisation of basic logistics infrastructure in our dual economy FE Van Dyk, MA Marais, AH Naude, IA Meyer, R Koen, EN Ralehoko, ... CSIR Centre for Logistics and Decision Support, 2005 | 2 | 2005 |
| P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5 … BL Rapoport, SD Moodley, C Jacobs, R Pienaar, S Fourie, WM Szpak The Breast, S64, 2007 | 1 | 2007 |
| Interim Analyses LANREL07484: Response to Treatment and Self-Reported Satisfaction in Symptoms in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with … D Geldenhuys, C Jacobs, B Rapoport, S Fourie, W Szpak, S Rodrigues, ... NEUROENDOCRINOLOGY 106, 194-194, 2018 | | 2018 |
| Interim Analyses LANREL07484: Quality of Life in Patients with Symptomatic Gastroenteropancreatic Neuroendocrine Tumors Treated with Lanreotide Autogel in South Africa D Geldenhuys, C Jacobs, B Rapoport, S Fourie, W Szpak, S Rodrigues, ... NEUROENDOCRINOLOGY 106, 193-193, 2018 | | 2018 |
| On a scheduling problem in the packaging industry AP Burger, CG Jacobs, JH van Vuuren, SE Visagie | | 2009 |
| KEYNOTE-555 Cohort B: Efficacy, Safety and Pharmacokinetics of Pembrolizumab 400 mg Every 6 Weeks as First-Line Therapy for Advanced Melanoma C Jacobs, B Rapoport, SW Chan, P Ruff, AA Fernandez, KM Eizmendi, ... | | |
